A detailed history of Nea Management Company, LLC transactions in Allakos Inc. stock. As of the latest transaction made, Nea Management Company, LLC holds 6,147,260 shares of ALLK stock, worth $7.93 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
6,147,260
Previous 6,147,260 -0.0%
Holding current value
$7.93 Million
Previous $6.15 Million 35.01%
% of portfolio
0.31%
Previous 0.58%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$5.66 - $8.42 $8,173 - $12,158
-1,444 Reduced 0.02%
6,147,260 $51.8 Million
Q3 2022

Nov 14, 2022

BUY
$3.02 - $6.12 $12 Million - $24.4 Million
3,984,000 Added 184.04%
6,148,704 $33.9 Million
Q4 2020

Feb 16, 2021

SELL
$79.58 - $152.45 $8.24 Million - $15.8 Million
-103,484 Reduced 4.56%
2,164,704 $303 Million
Q3 2018

Nov 13, 2018

BUY
$31.25 - $47.64 $70.9 Million - $108 Million
2,268,188 New
2,268,188 $102 Million

Others Institutions Holding ALLK

About Allakos Inc.


  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $109M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track This Portfolio

Track Nea Management Company, LLC Portfolio

Follow Nea Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nea Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nea Management Company, LLC with notifications on news.